RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000058.xml
Planta Med 1989; 55(5): 423-428
DOI: 10.1055/s-2006-962057
DOI: 10.1055/s-2006-962057
Papers
© Georg Thieme Verlag Stuttgart · New York
Mechanisms of Hypoglycemic Activity of Ganoderan B: A Glycan of Ganoderma lucidum Fruit Bodies1
1 Antidiabetes drugs, Part 33. Also Part 135 in the series on the validity of the Oriental medicinesWeitere Informationen
Publikationsverlauf
1988
Publikationsdatum:
24. Januar 2007 (online)
Abstract
Ganoderan B increased the plasma insulin level in normal and glucose-loaded mice but elicited no effect on insulin binding to isolated adipocytes. Administration of ganoderan B elicited significant increases of the activities of hepatic glucokinase, phosphofructokinase and glucose-6-phosphate dehydrogenase, decreased the hepatic glucose-6-phosphatase and glycogen synthetase activities and did not affect the activities of hexokinase and glycogen phosphorylase. Ganoderan B reduced the glycogen content in the liver but had no influence on total cholesterol and triglyceride levels in the plasma and liver.